デンマークのバイオテクノロジー・スタートアップBactolifeが、Healthgevityとの提携により米国市場に参入しました。結合タンパク質のブランド「Helm」から、腸の健康をサポートするサプリメント「Gutgevity」を発売しています。

Danish biotech startup Bactolife has teamed up with Healthgevity to bring its Helm line of binding proteins to the US, starting with a Gutgevity supplement for gut wellness. Months after securing €30M to bring its binding proteins to the US, Danish firm Bactolife is now making its debut stateside with Healthgevity. Binding proteins are a new class of food and dietary ingredients inspired by the IgG fragments found in immunoglobulins in the milk of camelids (a family of mammals including camels, alpacas and llamas), which gently bind and neutralise unhealthy compounds in the gut to support a healthier, more balanced microbiome. Bactolife uses precision fermentation to engineer microbes to produce and scale these proteins, with the tech complementing existing microbiome-based approaches – including probiotics, prebiotics and postbiotics – to add a “nourishing and protective layer” to gut wellness. The startup sells its binding proteins under its ingredient brand, Helm. Now, it has teamed up with Miami-based healthy ageing company Healthgevity to debut its first ingredient in the US, a dietary supplement called Gutgevity. “Our partnership with Bactolife gives healthcare practitioners access to a new mechanism through Helm Binding Proteins,” said Healthgevity founder and CEO Michael Antonelli. “By incorporating this technology...

This week, we tracked more than 35 tech funding deals worth over €407 million and 5 exits, M&A transactions, rumours, and related news stories

Danish biotech startup Bactolife has raised €30M ($35M) to launch its precision-fermented binding proteins in the US to boost gut health.

In the Center for Antibody Technologies, we strive to use scientific research to solve problems […]

Danish biotech start-up Bactolife secures major funding to scale precision-fermented proteins for food, supplement and feed markets.

Danish biotech startup Bactolife has raised €30M ($35M) to launch its precision-fermented binding proteins in the US to boost gut health.

Binding proteins selectively lock on to metabolites produced by harmful microbes in the gut and prevent them from crossing the gut barrier.

Binding proteins neutralize harmful bacteria without disrupting the microbiome by locking on to toxins produced by the bacteria.

精密発酵により腸内健康を促進する結合タンパク質を開発するデンマークのバイオテクノロジー企業Bactolifeが、米国のウェルネス市場への進出に向け、シリーズBラウンドで3,000万ユーロ（約54億9,000万円）超の資金調達を行ったと発表しました。

Bactolife, a Danish startup on a mission to unlock a novel category of gut health ingredients with binding proteins, has raised a €30 million+ ($35 million+) Series B round to commercialize its technology. Led by Cross Border Impact Ventures (CBIV)...

Bactolife, a Danish startup on a mission to unlock a novel category of gut health ingredients with binding proteins, is aiming to launch its first products in the US market next year. Probiotics (live microorganisms that confer health benefits) add...